Opportunity Information: Apply for RFA RM 22 012
The National Institutes of Health (NIH) released this funding opportunity to stand up a Tissue Procurement Center that will serve as a core, network-wide resource for the Somatic Mosaicism across Human Tissues (SMaHT) Program. SMaHT is focused on understanding how somatic genomic variation, meaning DNA changes that arise after conception and are present in only some cells, contributes to basic human biology and to disease mechanisms. The Tissue Procurement Center is meant to be the practical engine that makes this research possible at scale by reliably sourcing and delivering high-quality human tissue specimens that can be used across the SMaHT Network for consistent, comparable analyses.
This opportunity uses a cooperative agreement mechanism (U24), which typically means the awardee will not just receive funds and operate independently, but will work closely with NIH program staff and other SMaHT Network components to meet shared milestones, standards, and timelines. The FOA is explicitly labeled "Clinical Trial Not Allowed," signaling that the funded work should not be structured as a clinical trial and should instead focus on procurement, processing, storage, characterization, and distribution activities that enable research rather than testing clinical interventions.
The core deliverable is ambitious and specific: the Tissue Procurement Center is expected to collect, process, store, and rapidly distribute at least 15 distinct types of high-quality, well-characterized human tissues. These tissues must be recovered from a minimum of 150 individual donors, and the recruitment should draw from a diverse pool of donors. In practice, this implies the Center will need strong operational capacity in donor recruitment and consent (as applicable), coordination with clinical or recovery partners, standardized tissue handling and preservation workflows, robust quality systems, and a logistics pipeline that supports timely shipment and tracking. "Well-characterized" also implies accompanying documentation and metadata that make specimens maximally useful to downstream researchers, such as provenance, handling conditions, and other relevant specimen annotations, all managed under appropriate ethical and regulatory safeguards.
From an eligibility standpoint, the FOA is broad and is not limited to universities. Eligible applicants include many types of U.S.-based organizations and governmental entities: state, county, and local governments; special districts; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other organizations that meet NIH requirements. The announcement also calls out additional eligible groups, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions. At the same time, it clearly restricts foreign participation: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined in the NIH Grants Policy Statement) are not allowed.
Administratively, the opportunity is listed as discretionary funding and uses the cooperative agreement funding instrument type. The activity category is health, and it is associated with CFDA number 93.310. The opportunity number is RFA-RM-22-012, and NIH is the sponsoring agency. The source information provided indicates an original application closing date of July 8, 2022, and a creation date of February 23, 2022. The award ceiling and expected number of awards are not specified in the provided excerpt, which usually means applicants would need to consult the full FOA text or NIH notices for budget expectations, project period, and the anticipated number of funded centers.
Overall, this grant is best understood as infrastructure funding for a centralized, high-throughput tissue procurement and distribution operation that enables the SMaHT research ecosystem. The scientific payoff NIH is aiming for is a large, diverse, rigorously handled tissue resource that allows the network to detect and interpret somatic mosaicism across multiple tissues and many individuals, which in turn can reveal new disease pathways and biological principles that are difficult to observe with smaller, less standardized collections.Apply for RFA RM 22 012
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.310.
- This funding opportunity was created on 2022-02-23.
- Applicants must submit their applications by 2022-07-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Cooperative Agreement for affiliated Partner with Great Lake – Northern Forest Cooperative Ecosystem Studies Unit (CESU)
Previous opportunity: Bureau of Land Management Utah Recreation and Visitor Services
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA RM 22 012
Applicants also applied for:
Applicants who have applied for this opportunity (RFA RM 22 012) also looked into and applied for these:
| Funding Opportunity |
|---|
| Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 015 Funding Number: RFA AG 23 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Inter-Organelle Communication as a Platform to Interrogate the Interactions of Hallmarks of Aging (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 012 Funding Number: RFA AG 23 012 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 013 Funding Number: RFA AG 23 013 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Noncoding RNAs in Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 010 Funding Number: RFA AG 23 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed) Apply for RFA AG 23 011 Funding Number: RFA AG 23 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) Apply for PAR 22 128 Funding Number: PAR 22 128 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional) Apply for PAR 22 122 Funding Number: PAR 22 122 Agency: National Institutes of Health Category: Health Funding Amount: $3,000,000 |
| The Role of Dentistry in the Prevention of Opioid Drug Misuse and Abuse (UG3/UH3 Clinical Trial Optional) Apply for RFA DE 23 010 Funding Number: RFA DE 23 010 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) Apply for PAR 22 119 Funding Number: PAR 22 119 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R21 Clinical Trial Not Allowed) Apply for RFA DE 23 003 Funding Number: RFA DE 23 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R01 Clinical Trial Not Allowed) Apply for RFA DE 23 002 Funding Number: RFA DE 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) Apply for PAR 22 107 Funding Number: PAR 22 107 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed) Apply for RFA OD 22 003 Funding Number: RFA OD 22 003 Agency: National Institutes of Health Category: Health Funding Amount: $3,800,000 |
| NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) Apply for PAR 22 135 Funding Number: PAR 22 135 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional) Apply for RFA OD 22 004 Funding Number: RFA OD 22 004 Agency: National Institutes of Health Category: Health Funding Amount: $4,000,000 |
| Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 22 022 Funding Number: RFA AI 22 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed) Apply for PAR 22 118 Funding Number: PAR 22 118 Agency: National Institutes of Health Category: Health Funding Amount: $230,000 |
| Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed) Apply for RFA AI 22 019 Funding Number: RFA AI 22 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) Apply for PAR 22 104 Funding Number: PAR 22 104 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| International Bioethics Research Training Program (D43 Clinical Trial Optional) Apply for PAR 22 116 Funding Number: PAR 22 116 Agency: National Institutes of Health Category: Health Funding Amount: $230,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA RM 22 012", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
